// App-Quantinova.ai

P2-01-03 : Truncated HER2 Receptor in Circulating Tumor Cells (CTCs) of Early and Metastatic Breast Cancer Patients

Researchers

Presenter

  • Kallergi G

Principal Investigators

  • Nasias D

  • Papadaki M

  • Mavroudis D

  • Georgoulias V

  • Agelaki S

Medical Centers

  • University General Hospital of Heraklion, Heraklion, Greece

  • University of Crete, Heraklion, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Peripheral blood mononuclear cell

  • Circulating tumor cells

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved